-- 根據週二提交給澳洲證券交易所的文件顯示,美國鋁業公司(ASX:AAI)及其子公司荷蘭鋁業控股公司(Alcoa Nederland Holding)和其他關聯公司,已與一家銀團修改了其現有的12.5億澳元循環信貸協議。 文件稱,此次修改將信貸期限延長至2028年6月27日,並取消了部分定價要素,包括擔保隔夜融資利率利差調整以及與永續發展掛鉤的利率和費用調整。 文件也補充道,該公司向同意修改的各參與貸款機構一次性支付了一筆修改費,金額約為各貸款機構承諾額的0.1%。 週二交易中,美國鋁業公司股價下跌1%。
Related Articles
Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers
Telix Pharmaceuticals' (ASX:TLX) investigational imaging agent TLX250-Px has the potential to help diagnose kidney cancers beyond just clear cell renal cell carcinoma, or ccRCC, the company said Tuesday, citing an independent analysis published in the European Urology scientific journal.The analysis of phase three trial data showed that positive PET scan findings were "highly predictive" of malignancy overall, including in non-clear cell renal cell carcinoma, with a reported positive predictive value of 98%, the company said."Essentially all false-positives for ccRCC in the ZIRCON study have now been shown to be other malignant kidney cancer subtypes, reducing the risk of overtreatment and further supporting clinical adoption," said Telix Group Chief Medical Officer David Cade.
Huajin International Chairman, CEO Face Consumption Restriction Order
Huajin International (HKG:2738) said its chairman and chief executive were subject to a consumption restriction order due to the alleged nonpayment of amounts owed, according to a Hong Kong bourse filing Tuesday.The company's chairman Xu Songqing and chief executive Chen Chunniu have been subject to the consumption restriction order, effective Nov. 25.The case stems from the alleged non-payment of 130 million yuan by two of the company's units Jiangmen Huamu Metals and Jiangmen Huajin Metal Product, under a finance lease arrangement. As of April 30, 16.4 million yuan was still owed to the creditors.Both Xu and Chen have been negotiating with creditors to resolve the matter and the company expects to reach a settlement by the end of August.
Tata Chemicals' Consolidated Loss Widens in Fiscal Q4
Tata Chemicals' (NSE:TATACHEM, BOM:500770) consolidated attributable loss widened to 21.3 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 1.56 billion rupees a year ago.Loss per share grew to 83.68 rupees compared with a loss per share of 2.19 rupees a year earlier, the chemicals manufacturer said in a filing to the Indian bourses on Monday.Revenue from operations in fiscal Q4 declined to 34.4 billion rupees from 35.1 billion rupees a year ago. This was lower than the 34.8 billion rupees estimated by analysts polled by Visible Alpha.The company's board recommended a dividend of 11 rupees per share for the financial year ended March 31.